Davis George Eric's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed Apr 1, 2024
- Accession no.
- 0001048477-24-000054
- Filed
- Apr 1, 2024
- Trade date
- Mar 28, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.17M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis George EricCIK 0001380710 | Officer (EVP, Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | Common Stock | SSaleDisposed | −24,602 | $88.34 | −$2,173,340.68 | 55,856 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.